India overtakes Iran in clinical trial initiations outside North America and Europe in Q2 2025 Read more
FDA discontinue rare pediatric disease designation program despite increase in RPD approvals Read more
FDA approves 127 innovator and biosimilar drugs in 2024, marks shift in pharma approval landscape Read more
CDC’s vaccine advisory committee overhaul raises concerns for vaccine oversight: GlobalData Read more
Big Pharma prepare for next patent cliff as blockbuster drugs revenue losses loom: GlobalData Read more
High costs and limited access threaten progress in HIV treatment despite new drug advances: GlobalData Read more